Fig. 1From: Successful treatment by on-demand glecaprevir and pibrentasvir for hepatitis C flare during R-CHOP in patients with diffuse large B-cell lymphoma: a case reportVirologic response and clinical course of glecaprevir and pibrentasvir therapy for HCV and hepatitis flare during R-CHOP for DLBCL. Changes in the serum hepatitis C virus (HCV) titer, alanine aminotransferase (ALT), and aspartate aminotransferase (AST) are shown. HCV, hepatitis C virus; ALT, alanine transaminaseBack to article page